Corpus Intelligence IC Memo — CATHOLIC MEDICAL CENTER 2026-04-26 09:05 UTC
IC Memo — CATHOLIC MEDICAL CENTER
Investment Committee Memorandum | NH | 262 beds | Grade B | EBITDA uplift $34.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CATHOLIC MEDICAL CENTER

CCN 300034 | HILLSBOROUGH, NH | 262 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CATHOLIC MEDICAL CENTER is a 262-bed suburban community hospital in HILLSBOROUGH, NH with $470.4M in net patient revenue and a -4.2% operating margin. The hospital serves a payer mix of 35.2% Medicare, 2.2% Medicaid, and 62.6% commercial.

Thesis: Undervalued. Our ML models identify $34.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.2% to 3.2% (+736bps).

Net Revenue HCRIS$470.4M
Current EBITDA COMPUTED$-19.7M
Operating Margin COMPUTED-4.2%
Occupancy HCRIS69.8%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS28.7%
Distress Probability ML42.9%

2. Market Context & Competitive Position

30
NH Hospitals
-2.7%
State Median Margin
8
Comparable Hospitals

NH has 30 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of -4.2% places it below the state median. Among 8 size-comparable peers (131-524 beds), the median margin is -0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (131-524), prioritizing same-state peers. 8 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CATHOLIC MEDICAL CENTER (Target)NH262$470.4M-4.2%
MARY HITCHCOCK MEMORIAL HOSPNH456$1.43B-33.9%
ELLIOT HOSPITALNH215$660.8M14.5%
CONCORD HOSPITAL INC.NH206$553.5M-5.1%
PORTSMOUTH REGIONAL HOSPITALNH168$347.4M45.5%
SOUTHERN NH MEDICAL CENTERNH138$293.0M-0.8%
ST. JOSEPH HOSPITALNH160$236.2M-15.1%
NORTHEAST REHABILITATION HOSPINH135$102.7M-0.2%
NEW HAMPSHIRE HOSPITALNH184$nannan%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $34.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.9M+210bp18mo
Cost to Collect4.5%2.5%$9.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.7M+122bp9mo
Clean Claim Rate88.0%96.0%$301K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.9M
Cost to Collect
$9.4M
Denial Rate Reduction
$9.3M
A/R Days Reduction
$5.7M
Clean Claim Rate
$301K
Total EBITDA Uplift$34.6M
Current EBITDA$-19.7M
+ RCM Uplift+$34.6M
Pro Forma EBITDA$14.9M
Current Margin-4.2%
Pro Forma Margin3.2%
WC Released (1x)$18.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-30.3M$216.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-30.3M$227.9M0.00x-100.0%
Bull Case9.0x11.0x$-27.3M$332.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-27.3M$354.4M0.00x-100.0%
Bear Case11.0x10.0x$-33.4M$52.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-33.4M$47.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 8 hospitals with 131-524 beds
  • Same-state prioritization (n=9)
  • Comp margins: P25=-10.1% / P50=-0.8% / P75=7.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.